NCT01426633View on ClinicalTrials.gov

Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
LeiomyosarcomaLiposarcoma
Interventions
DRUG

Gemcitabine + Trabectedin

Combination therapy of gemcitabine and trabectedin

Trial Locations (1)

68167

Mannheim University Medical Center, Mannheim

All Listed Sponsors
lead

Heidelberg University

OTHER

NCT01426633 - Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas | Biotech Hunter | Biotech Hunter